New pioneering research conducted by scientists from the lab of Mikhail Shapiro, ICB project leader and Caltech professor of Chemical Engineering, has demonstrated a new mechanism for reducing cancerous tumor growth and overcomes the limitations of most current microbial cancer therapies with the use of genetically engineered therapeutic bacteria that are remotely controlled by thermal focused ultrasound (FUS).